Arcutis Biotherapeutics, Inc. has launched roflumilast (Zoryve) cream 0.15% for treating mild to moderate atopic dermatitis (AD) in adults and children down to the age of 6 in the US. The treatment, approved earlier this month, offers a steroid-free,…